Eli Lilly and Suven enter CNS research deal
Drug giant Eli Lilly has joined forces with Suven Life Sciences in a deal that will focus on pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs